Steensma DP - Search Results

1

Phase 2 trial of imatinib mesylate in myelofibrosis with myeloid metaplasia.

Tefferi A, Mesa RA, Gray LA, Steensma DP, Camoriano JK, Elliott MA, Pardanani A, Ansell SM, Call TG, Colon-Otero G, Schroeder G, Hanson CA, Dewald GW, Kaufmann SH. Tefferi A, et al. Among authors: steensma dp. Blood. 2002 May 15;99(10):3854-6. doi: 10.1182/blood-2001-12-0154. Blood. 2002. PMID: 11986248 Free article. Clinical Trial.

2

Autoimmune hemolytic anemia in a patient with autosomal dominant chronic mucocutaneous candidiasis.

Steensma DP, Tefferi A, Weiler CR. Steensma DP, et al. Mayo Clin Proc. 2000 Aug;75(8):853-5. doi: 10.4065/75.8.853. Mayo Clin Proc. 2000. PMID: 10943243

3

Amifostine alone and in combination with erythropoietin for the treatment of favorable myelodysplastic syndrome.

Tefferi A, Elliott MA, Steensma DP, Hook CC, Dispenzieria A, Hanson CA, Schroeder G, Letendre L. Tefferi A, et al. Among authors: steensma dp. Leuk Res. 2001 Feb;25(2):183-5. doi: 10.1016/s0145-2126(00)00108-9. Leuk Res. 2001. PMID: 11166835

4

A high bone marrow plasma cell labeling index in stable plateau-phase multiple myeloma is a marker for early disease progression and death.

Steensma DP, Gertz MA, Greipp PR, Kyle RA, Lacy MQ, Lust JA, Offord JR, Plevak MF, Therneau TM, Witzig TE. Steensma DP, et al. Blood. 2001 Apr 15;97(8):2522-3. doi: 10.1182/blood.v97.8.2522. Blood. 2001. PMID: 11290618 Free article. Review.

5

Clarifications to the standard neutrophil response criteria for clinical trials in myelodysplastic syndromes are needed.

Steensma DP, Letendre L, Tefferi A. Steensma DP, et al. Blood. 2001 May 15;97(10):3321-2. doi: 10.1182/blood.v97.10.3321. Blood. 2001. PMID: 11368066 Free article. No abstract available.

6

Myelodysplasia with fibrosis: a distinct entity?

Steensma DP, Hanson CA, Letendre L, Tefferi A. Steensma DP, et al. Leuk Res. 2001 Oct;25(10):829-38. doi: 10.1016/s0145-2126(01)00055-8. Leuk Res. 2001. PMID: 11532514 Review. No abstract available.

7

Etanercept, a soluble tumor necrosis factor receptor, palliates constitutional symptoms in patients with myelofibrosis with myeloid metaplasia: results of a pilot study.

Steensma DP, Mesa RA, Li CY, Gray L, Tefferi A. Steensma DP, et al. Blood. 2002 Mar 15;99(6):2252-4. doi: 10.1182/blood.v99.6.2252. Blood. 2002. PMID: 11877307 Free article. Clinical Trial.

8

Myelodysplastic syndrome and pregnancy: the Mayo Clinic experience.

Steensma DP, Tefferi A. Steensma DP, et al. Leuk Lymphoma. 2001 Nov-Dec;42(6):1229-34. doi: 10.3109/10428190109097747. Leuk Lymphoma. 2001. PMID: 11911403

9

Hydroxyurea-associated platelet count oscillations in polycythemia vera: a report of four new cases and a review.

Steensma DP, Harrison CN, Tefferi A. Steensma DP, et al. Leuk Lymphoma. 2001 Nov-Dec;42(6):1243-53. doi: 10.3109/10428190109097749. Leuk Lymphoma. 2001. PMID: 11911405

10

Low-dose, single-fraction, whole-lung radiotherapy for pulmonary hypertension associated with myelofibrosis with myeloid metaplasia.

Steensma DP, Hook CC, Stafford SL, Tefferi A. Steensma DP, et al. Br J Haematol. 2002 Sep;118(3):813-6. doi: 10.1046/j.1365-2141.2002.03695.x. Br J Haematol. 2002. PMID: 12181050 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

498 results

Search Page

Filters